Nokia introduces industry’s first carrier-grade Wi-Fi 7 product portfolio
Press Release
Nokia introduces industry’s first carrier-grade Wi-Fi 7 product portfolio
- Nokia unveils extensive portfolio of carrier-grade Wi-Fi 7 broadband devices to the market that are more than 3x faster than Wi-Fi 6.
- New portfolio of Wi-Fi 7 products includes a dual-band 5G FWA gateway, a tri-band fiber ONT gateway, and the flagship Beacon 24, a quad-band device that can provide a total Wi-Fi capacity of up to 24Gbps.
- All Wi-Fi 7 products are powered by Nokia’s Corteca software, allowing CSPs to monetize new services, delivering a better user experience, and reducing their operational expense.
23 October, 2023
Espoo, Finland – Nokia today announced a new carrier-grade portfolio of Wi-Fi 7 devices that ensure end-users receive the ultimate broadband experience, whether they’re streaming, online gaming, or doing video calls. Supporting a range of low- and high-end devices, the new portfolio includes dual-band, tri-band and quad-band configurations to address various regulatory constraints and meet market demands.
Nokia’s Wi-Fi 7 portfolio offers unique capabilities. The Beacon 24 has an innovative antenna design and orientation for omnidirectional coverage, which provides the best overall horizontal coverage, as well as vertical coverage for Wi-Fi devices on different floors. In addition, Nokia’s Beacon 24 supports multi-link operations (MLO) across four radio links. MLO is a new concept in Wi-Fi 7 that revolutionizes Wi-Fi connection speeds, by enabling devices to simultaneously send and receive data across different frequency bands and channels.
The Wi-Fi 7 portfolio is powered by Nokia’s Corteca software. Nokia Corteca works end-to-end, from applications embedded in the device, through the home, and into the cloud. This end-to-end approach maximizes Wi-Fi performance at every opportunity. Corteca brings advanced Wi-Fi and device management, is based on open industry standards (TR-369, EasyMesh) and offers a marketplace with applications -including 3rd party- that run on fiber (ONT) gateways, FWA gateways, and mesh Wi-Fi beacons.
Justin Doucette, head of Wi-Fi for Fixed Networks Broadband Devices at Nokia, said: “The world is moving to multi-gigabit with 25G fiber and 5G mmWave pushing the broadband speeds to the home to new heights. Wi-Fi 7 provides new capabilities that ensure these multi-gigabit broadband services can be achieved throughout the home. The combination of our new Wi-Fi 7 devices and our Corteca software gives operators the tools they need to deliver an unsurpassed broadband experience”
Michael Philpott, Research Director, Digital Consumer Services at Omdia said: “Wi-Fi 7 sets the stage for a faster, more connected future. However any solution that is deployed should be compliant with the final Wi-Fi Alliance standard which will be critical to interoperability. The standard will ensure that Wi-Fi devices work seamlessly together, delivering the quality and connectivity we all depend on in the digital world.”
The new Nokia portfolio of Wi-Fi 7 solutions will be fully certified and compliant with the standard expected to be finalized in early 2024. The full set of Nokia Wi-Fi solutions will be available in 1H2024.
Resources and additional information
- Webpage: Broadband devices for the best in-home experience
- The Beacon 24 is a quad band 4+4+4+4 Wi-Fi 7 mesh extender, delivering up to 24 Gbps over Wi-Fi -- https://www.nokia.com/networks/fixed-networks/nokia-wifi-beacon-24/
- The 5G Gateway 7 is a dual-band 4+4 Wi-Fi 7 FWA Gateway, delivering up to 7 Gbps over Wi-Fi -- https://www.nokia.com/networks/fixed-networks/fastmile/5g-gateway-7
- The Nokia XS-2437X-A is a tri-band 4+4+4 XGSPON Wi-Fi 7 ONT Gateway, delivering up to 19 Gbps over Wi-Fi -- https://www.nokia.com/networks/fixed-networks/nokia-ONT-XS-2437X-A/
About Nokia
At Nokia, we create technology that helps the world act together.
As a B2B technology innovation leader, we are pioneering networks that sense, think and act by leveraging our work across mobile, fixed and cloud networks. In addition, we create value with intellectual property and long-term research, led by the award-winning Nokia Bell Labs.
Service providers, enterprises and partners worldwide trust Nokia to deliver secure, reliable and sustainable networks today – and work with us to create the digital services and applications of the future.
Media inquiries
Nokia Communications, Corporate
Email: Press.Services@nokia.com
Follow us on social media
LinkedInTwitterInstagramFacebookYouTube
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Managers’ transactions9.12.2023 18:12:40 CET | Press release
December 9, 2023 Announcement no. 21 Managers’ transactions COPENHAGEN, DENMARK and BOSTON, MA, December 9, 2023, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or the Company) (CPH:BIOPOR), has received notice pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transaction related to shares in BioPorto made by persons discharging managerial responsibilities in BioPorto and/or persons closely related with them. 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Singer Asefzadeh Family Holding Trust 2. Reason for the notification a) Position/status Closely associated person to Michael S. Singer, member of the Board of Directors of BioPorto A/S b) Initial notification/amendment Initial notification 3. Details of the issuer a) Name BioPorto A/S b) LEI 5299004SWFL5JAN4W830 4. Details of the transaction(s) a) Description of the financial instrument type of instrument and Identification code Shares, ISIN code DK0011048619 b) Nature o
New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)9.12.2023 18:00:00 CET | Press release
Media Release COPENHAGEN, Denmark; December 9, 2023 Data from the pivotal phase 1/2 EPCORE™ NHL-1 study showed 82 percent overall response rate (ORR), 63 percent complete response (CR) and 67 percent minimal residual disease (MRD) negativity in patients with relapsed/refractory (R/R) follicular lymphoma (FL) treated with subcutaneous epcoritamab Results presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition include data from an optimized step-up dosing schedule for FL patients showing meaningful reduction in risk and severity of cytokine release syndrome (CRS) Follicular lymphoma is the second most common form of non-Hodgkin’s lymphoma, is considered incurable and can be difficult to treat in the R/R setting Genmab A/S (Nasdaq: GMAB) and AbbVie (NYSE: ABBV) todayannounced new data from the ongoing phase 1/2 EPCORE™ NHL-1 clinical trial investigating epcoritamab (DuoBody® CD3xCD20), a T-cell engaging bispecific antibody administered subcutaneously, demo
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG51019.12.2023 18:00:00 CET | Press release
Additional safety and efficacy data further support potential of innovative, decentralized approach to CAR-T manufacturing and transformational impact on patients with severe hematologic cancersTwo poster presentations include recent data updates and additional data not included in the ASH abstracts Galapagos to host a Key Opinion Leader (KOL) event with live webcast on Sunday, 10 December 2023 at 11:00 am PT/20:00 CET Mechelen, Belgium; 9 December 2023, 18:00 CET; Galapagos NV (Euronext & NASDAQ: GLPG) topresent additional encouraging clinical data from the ongoing Phase 1/2 CD19 CAR-T studies, EUPLAGIA-1 with GLPG5201 and ATALANTA-1 with GLPG5101, in patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or without Richter transformation, and non-Hodgkin lymphoma (rrNHL), during two poster sessions at the 65th American Society of Hematology (ASH) Annual Meeting taking place in San Diego, from 9-12 December. “We are very pleased to share promising new data from o
New data reinforce the benefit of early preventative treatment with Roche’s Hemlibra for babies with severe haemophilia A9.12.2023 17:30:00 CET | Press release
Phase III HAVEN 7 primary data presented at ASH 2023 provide additional confidence in the favourable efficacy and safety profile of subcutaneous Hemlibra given soon after birth 1At nearly two years median follow-up in the descriptive, single-arm study, no babies experienced spontaneous bleeds requiring treatment, and all treated bleeds were as a result of trauma 1Safety results were consistent with previous studies of Hemlibra, with no new safety signals observed 1The HAVEN 7 study was developed in collaboration with the haemophilia A community, to generate additional evidence for the prophylactic treatment of infants with haemophilia A Basel, 09 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the primary analysis of the Phase III HAVEN 7 study reinforced the efficacy and safety of Hemlibra® (emicizumab) in previously untreated or minimally treated infants with severe haemophilia A without factor VIII inhibitors. Results showed that Hemlibra achieved meaningful
Bulletin from Annual General Meeting in SkiStar AB9.12.2023 16:00:00 CET | Press release
At SkiStar AB (publ)’s annual general meeting, held in Sälen on 9 December 2023, the following decisions were made. A dividend of SEK 2.60 per share was adopted. Record day 12 December 2023.Lena Apler, Fredrik Paulsson, Gunilla Rudebjer, Anders Sundström, Anders Svensson and Vegard Søraunet were re-elected to the board and Carina Åkerström was elected as new board member.Anders Sundström was re-elected chairman of the board.Board fees, including committee fees, were raised to a total of SEK 2,890,000 (2022: SEK 2,810,000). The fees shall be distributed as follows: SEK 670,000 (650,000) to the chairman of the board and SEK 310,000 (300,000) each to the other non-executive directors. Audit committee members will receive total fees of SEK 240,000 (unchanged), distributed as follows: SEK 120,000 to the committee chairman and SEK 60,000 to each of the other two members. Remuneration committee members will receive total fees of SEK 120,000 (unchanged), distributed as follows: SEK 60,000 to t